Skip to content

Clinical Study of Absorbable Fixation Screws for Chronic Ankle Instability

Safety and Effectiveness of a Novel Absorbable Tendon/Ligament Repair Implant for Chronic Ankle Instability Repair: A Prospective, Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128429
Enrollment
Unknown
Registered
2026-07-20
Start date
2026-07-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Ankle Instability (mainly characterized by recurrent lateral ankle sprains, giving way sensation, feeling of instability during walking or sports, pain, swelling, and limited activity)

Interventions

Control group:Established imported absorbable product
Experimental group:Novel absorbable tendon/ligament fixation screw.

Sponsors

Beijing Jishuitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years and 6 months) and failed conservative treatment; 3. No previous ipsilateral ankle-hindfoot surgery; 4. Able to understand the study purpose, voluntarily participate and sign informed consent, independently complete valid questionnaires, and willing to comply with the required clinical follow-up.

Exclusion criteria

Exclusion criteria: 1. Ankle osteoarthritis (Takakura stage 3a or higher); 2. Previous ipsilateral ankle ligament surgery; 3. Patients with severe hepatic or renal insufficiency, serious cardiovascular, cerebrovascular or other severe diseases; 4. Systemic connective tissue disease or metabolic bone disease; 5. Pregnant or breastfeeding women; 6. Other severe systemic diseases making the patient unable to tolerate surgery; 7. Currently participating in another drug or medical device clinical trial and not yet reached its primary endpoint; 8. Patients considered unsuitable for participation in this clinical trial by the investigator for any other reason;

Design outcomes

Primary

MeasureTime frame
Karlsson Ankle Score postoperatively;Incidence of intraoperative and short-term (=6 months) adverse events;

Secondary

MeasureTime frame
Blood biochemistry (liver function: ALT, AST; renal function: Cr, BUN; electrolytes: Ca, P);Patient satisfaction score;Complete blood count;Ligament healing assessed by ankle MRI;Postoperative Tegner Activity Score;Karlsson Ankle Score at 6 weeks and 3 months postoperatively;Postoperative AOFAS Ankle-Hindfoot Score;Postoperative VAS pain score;

Countries

China

Contacts

Public ContactXiaofeng Gong

Beijing Jishuitan Hospital, Capital Medical University

3104@jst-hosp.com.cn+86 10 50963920

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026